Global Shift in R&D

A new analysis of global biomedical research and development investments shows that the US is losing some of its dominance, as industry science funding in the US, in particular, has lagged just as countries in Asia and Oceania have been spending more on R&D.

The analysis of global R&D trends between 2007 and 2012, published in the New England Journal of Medicine, found that the US share of global biomedical research spending declined over the last five years from 51 percent to below 45 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.